Zobrazeno 1 - 10
of 125
pro vyhledávání: '"FREZZETTI A"'
Autor:
Frezzetti, Daniela1 (AUTHOR) d.frezzetti@istitutotumori.na.it, Caridi, Vincenza1 (AUTHOR) vincenza.caridi@istitutotumori.na.it, Marra, Laura1 (AUTHOR) laura.marra@istitutotumori.na.it, Camerlingo, Rosa1 (AUTHOR) r.camerlingo@istitutotumori.na.it, D'Alessio, Amelia2 (AUTHOR) al.dalessio@aslsalerno.it, Russo, Francesco3 (AUTHOR) f.russo@ieos.cnr.it, Dotolo, Serena1 (AUTHOR) serena.dotolo@istitutotumori.na.it, Rachiglio, Anna Maria1 (AUTHOR) am.rachiglio@istitutotumori.na.it, Esposito Abate, Riziero1 (AUTHOR) r.espositoabate@istitutotumori.na.it, Gallo, Marianna1 (AUTHOR) marianna.gallo@istitutotumori.na.it, Maiello, Monica Rosaria1 (AUTHOR) m.maiello@istitutotumori.na.it, Morabito, Alessandro4 (AUTHOR) a.morabito@istitutotumori.na.it, Normanno, Nicola1 (AUTHOR) a.deluca@istitutotumori.na.it, De Luca, Antonella1 (AUTHOR)
Publikováno v:
International Journal of Molecular Sciences. May2024, Vol. 25 Issue 9, p4844. 17p.
Autor:
Nicola Normanno, Paolo Chiodini, Riziero Esposito Abate, Raffaella Pasquale, Alessandra Sacco, Vittorio Simeon, Monica Rosaria Maiello, Daniela Frezzetti
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 2 (2024)
Background Although conflicting results emerged from different studies, the tumor mutational burden (TMB) appears as one of most reliable biomarkers of sensitivity to immune checkpoint inhibitors. Several laboratories are reporting TMB values when pe
Externí odkaz:
https://doaj.org/article/d22bb570ecbd49d5be9ee43d7c0ddb86
Autor:
Daniela Frezzetti, Vincenza Caridi, Laura Marra, Rosa Camerlingo, Amelia D’Alessio, Francesco Russo, Serena Dotolo, Anna Maria Rachiglio, Riziero Esposito Abate, Marianna Gallo, Monica Rosaria Maiello, Alessandro Morabito, Nicola Normanno, Antonella De Luca
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 9, p 4844 (2024)
Epidermal growth factor receptor (EGFR)-mutant non-small-cell lung cancer (NSCLC) patients treated with EGFR–tyrosine kinase inhibitors (TKIs) inevitably develop resistance through several biological mechanisms. However, little is known on the mole
Externí odkaz:
https://doaj.org/article/5ac86a96fa2d446fbcd5ae1a2edd00d9
Autor:
Marco Albanesi, Diletta Cozzi, Edoardo Cavigli, Chiara Moroni, Gianluca Frezzetti, Lina Bartolini, Vittorio Miele
Publikováno v:
Tomography, Vol 8, Iss 2, Pp 1041-1051 (2022)
Since the first report of the outbreak in Wuhan, China in December 2019, as of 1 September 2021, the World Health Organization has confirmed more than 239 million cases of the novel coronavirus (SARS-CoV-2) infectious disease named coronavirus diseas
Externí odkaz:
https://doaj.org/article/1551a848d82444fdb0b84b4684eea8ee
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Frezzetti, Antonio, Manfredi, Sabato
Publikováno v:
In Control Engineering Practice November 2019 92
Autor:
Cristin Roma, Alessandra Sacco, Laura Forgione, Riziero Esposito Abate, Matilde Lambiase, Serena Dotolo, Monica Rosaria Maiello, Daniela Frezzetti, Guglielmo Nasti, Alessandro Morabito, Antonella De Luca, Nicola Normanno
Publikováno v:
Diagnostics, Vol 12, Iss 8, p 1956 (2022)
Targeted sequencing of circulating cell-free DNA (cfDNA) is used in routine clinical diagnostics for the identification of predictive biomarkers in cancer patients in an advanced stage. The presence of KRAS mutations associated with clonal hematopoie
Externí odkaz:
https://doaj.org/article/3b3e10b48f474c70889e70aa7321a047
Publikováno v:
In Control Engineering Practice November 2015 44:45-54
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Marianna Gallo, Marianeve Carotenuto, Daniela Frezzetti, Rosa Camerlingo, Cristin Roma, Francesca Bergantino, Nicola Normanno, Antonella De Luca
Publikováno v:
Cancers; Volume 14; Issue 7; Pages: 1851
We previously demonstrated that the epidermal growth factor receptor (EGFR) modulates in mesenchymal stem cells (MSCs) the expression of a number of genes coding for secreted proteins that promote breast cancer progression. However, the role of the E